UL138 has also been found to affect surface levels of Epidermal Growth Factor Receptor (EGFR), with increased signaling activity enhancing latent infection of CD34+ myeloid progenitor cells [38,39]. The gene discussed is EGFR; the disease is disease arising from reactivation of latent virus.